Murine CD5⁺, CD8⁺ Normal Fetal Liver Cells Enhance an Immune Response: Benzo(α) Pyrene-Exposed CD5⁺ Fetal Liver Cells are Inhibitors

REFERENCES

• A. Globerson, R. M. Zinkernagel, and T. Umiel. (1975). Immunosuppression by embryonic Liver cells. Transplant. 20:480–485.
   PubMedGoogle Scholar
• A. del Rey, A. H. Besedovsky, and H. Sorkin. (1980). Mouse fetal liver cells manifest antigen-specific suppressor activity. Cell. Immunol. 56:217.
   PubMedGoogle Scholar
• S. Muroaka, and R. Miller. (1983). GCells in murine fetal liver and lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J. Immunol. 131:45.
   PubMedGoogle Scholar
• P. Urso, and R. A. Johnson. (1987). Early changes in T lymphocytes and subsets of mouse progeny defective as adults in controlling growth of a syngeneic tumor after in utero insult with benzo(α)pyrene. Immunopharmacology 14:1.
   PubMed Web of Science ®Google Scholar
• P. Urso. (1995). Murine fetal liver augments proliferation in an allogeneic mixed lymphocyte culture: Benzo(α)pyrene reduces augmentation. Immunopharm. Immunotox. 17:181.
   PubMed Web of Science ®Google Scholar
• R. Haars, P. Conradt, I. Miltner, and H. Wagner. (1991). A novel form of CD4 (L3T4) mRNA in the murine fetal liver results in cell-surface expression of the L3T4 antigen. Scand. J. Immunol. 34:253.
   PubMedGoogle Scholar
• R. E. Mebius, T. Miyamoto, J. Christensen, J. Domen, T. Cupedo, I. L. Weissman, and K. Akashi. (2001). The fetal liver counterpart of adult common lymphoid progenitor gives rise to all lymphoid lineages, CD45+CD4+CD3- cells as well as macrophages. J. Immunol. 66:6593.
   Google Scholar
• S. Sagara, K. Sugaya, Y. Tokoro, S. Tanaka, H. Takano, H. Kodama, H. Nagauchi, and Y. Takahama. (1997). B220 expression by T lymphoid progenitor cells in mouse fetal liver. J. Immunol. 158:666.
   PubMedGoogle Scholar
• S. D. Holladay, and B. J. Smith. (1994). Fetal hematopoietic alterations after maternal exposure to benz(α)pyrene: A cytometric evaluation. J. Toxicol. Environ. Health. 42:259.
   PubMed Web of Science ®Google Scholar
• F. Douagi, J. Colucci, O. DiSanto, and M. A. Cuomano. (2002). Identification of the earliest rethymic bipotent T/NK progenitor in mouse liver. Blood. 99:463.
   PubMedGoogle Scholar
• C. Penit, and F. Vasseur. (1989). Cell proliferation in the fetal and early postnatal mouse thymus. J. Immunol. 142:3369. 1989
   PubMedGoogle Scholar
• E. Mertsching, A. I. Wurster, C. Katayama, J. Esko, F. Ramsdell, J. D. Marth, and S. M. Hedrick. (2002). A mouse strain active for αβ vs γδ T- cell lineage. Int. Immunol. 14:1039.
   PubMedGoogle Scholar
• D. Vremec, J. Pooley, H. Hochrein, L. Wu, and K. Shortman. (2000). CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
   PubMed Web of Science ®Google Scholar
• K. Takahashi, K. Miyakawa, A. A. Wynn, K. Nakayama, Y. Y. Myint, M. Naito, L. D. Shultz, A. Tominaga, and K. Takatsu. (1998). Effects of granulocyte/macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice. Am. J. Pathol. 152:445.
   PubMedGoogle Scholar
• R. R. Hardy, and K. Hayakawa. (1991). A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. U.S.A. 88:11550.
   PubMedGoogle Scholar
• A. N. Makori, A. F. Tarantal, F. X. Lu, T. R. Marthas, M. B. Chesney, A. G. Hendricks, and C. Miller. (2003). Functional and morphological development of lymphoid immune regulatory and effector function in rhesus monkey secreting cells, immunoglobulin secreting cells, and CD5 appear early in fetal development. Clin. Diagn. Lab. Immunol. 10:140.
   PubMedGoogle Scholar
• E. Payer, R. Kutil, and G. Stingl. (1994). CD5-dendritic epidermal T cells are derived from CD5+ precursor cells. Eur. J. Immunol. 24:1317. 1994
   PubMedGoogle Scholar
• H. S. Azzam, A. Grinberg, H. Lui, E. Shen, H. Shores, and P. E. Love. (1998). CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:2301.
   PubMed Web of Science ®Google Scholar
• G. Bikal, F. H. Lynd, A. A. Aruffo, J. A. Ledbetter, and S. Bondada. (1998). A role of CD5+ in cognate interactions between T and B cells, and identification of a novel ligand for CD5+. Int. Immunol. 10:1125–1131.
   Google Scholar
• P. Youinou, C. Jamin, J-O. Pers, C. Berthou, A. Saraux, and Y. Renaudineau. (2005). B lymphocytes are required for development and treatment of autoimmune disease. Ann. N.Y. Acad. Sci. 1050:19.
   PubMedGoogle Scholar
• J. W. Tung, S. S. Kunnavatana, L. A. Herzenberg, and L. A. Herzenberg. (2001). The regulation of CD5 expression in murine T cells. BMC Molec. Biol. 2:15.
   PubMedGoogle Scholar
• T. Kina, S. Nishikawa, and Y. Katsura. (1982). T-cell regulation of pokeweed-mitogen- induced polyclonal immunoglobulin production in mice. II. Mechanism of the induction of suppressor cells. Immunol. 46:583.
   PubMedGoogle Scholar
• F. Y. Liew, and S. M. Russell. (1980). Delayed type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J. Exp. Med. 151:799.
   PubMed Web of Science ®Google Scholar
• W. Luo, H. Van De Velde, I. Von Hoegen, J. R. Parnes, and K. Theilmans. (1992). Ly-1 (CD5), a member glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148:1630.
   PubMed Web of Science ®Google Scholar
• T. A. Thompson, C. H. Potter, I. F. C. McKenzie, and C. R. Parish. (1980). The surface phenotype of s suppressor cell of delayed-type hypersensitivity in the mouse. Immunol. 40:87.
   PubMedGoogle Scholar
• M. Raab, M. Yamamoto, and C. E. Rudd. (1994). The T cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck. Mol. Cell. Biol. 14:2862.
   PubMed Web of Science ®Google Scholar
• A. D. Davies, S. C. Ley, and M. J. Crumpton. (1992). CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl. Acad. Sci. U.S.A. 89:6368.
   PubMedGoogle Scholar
• N. Watanabe, S. Kojima, F-W. Shen, and Z. Ovary. (1977). Expression of IgE antibody production in SJL mice. Expression of Ly-1 antigen on helper and non-specific suppressor cells. J. Immunol. 118:485.
   PubMedGoogle Scholar
• M. O. Muench, M. G. Roncarlo, and R. Namikawa. (1997). Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood. 89:1364.
   PubMedGoogle Scholar
• M. Marchant, V. Appay, M. van der Sande, N. Dulphy, C. Liesnard, M. Kidd, S. Kaye, O. Ojuola, G. M. A. Gillespie, A. L. Vargas Cuero, V. Cerundolo, M. Callan, K. J. McAdam, P. W. S. L. Rowland-Jones, C. Donner, A. J. McMichael, and W. Whittle. (2003). Mature CD8+ T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111:1747.
   PubMed Web of Science ®Google Scholar
• G. T. Belz, J. D. Altman, and P. C. Doherty. (1998). Characteristics of virus-specific CD8+ cells in the liver during the control and resolution phases of influenza pneumonia. Immunol. 95:13812.
   Google Scholar
• L. E. Shields, L. Gaur, P. Dello, J. Potter, A. Sieverkropp, and R. G. Andrews. (2004). Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. Stem Cells. 22:759.
   PubMedGoogle Scholar
• A. B. Peck, and F. H. Bach. (1973). A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J. Immunol. Meth. 3:147.
   PubMed Web of Science ®Google Scholar
• P. Urso, N. Gengozian, L. R. Rossi, and R. A. Johnson. (1986). Suppression of the plaque forming cell response and the mixed lymphocyte response in vitro by benzo(α)pyrene. J. Immunopharm. Immunotox. 8:223.
   Google Scholar
• M. E. Lee, and P. Urso. (2007). Suppression of T lymphocyte proliferation to antigenic and mitogenic stimuli by benzo(α)pyrene and 2-aminofluorene metabolites. Immunopharm. Immunotox. 29:1.
   PubMedGoogle Scholar
• A. M. Thornton, and E. M. Shevach. (1998). CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 188:287.
   PubMed Web of Science ®Google Scholar
• S. K. Singhal, and A. K. Duwe. Suppressor B cells Suppressor cells in immunity: An International Symposium. S. K. Singhal, and N. R. St. C. Sinclair. The University of Western Toronto Press, TorontoOntario, (1975).
   Google Scholar
• V. S. Rao, J. A. Bennett, F. W. Shen, R. K. Gershon, and M. S. Mitchell. (1980). Antigen:antibody complexes generate Lyt 1 inducers of suppressor cells. J. Immunol. 125:63.
   PubMed Web of Science ®Google Scholar
• N. Koide, T. Sugiyama, I. Mori, M. M. Mu, T. Hamano, T. Yoshida, and T. Yokochi. (2002). Change of mouse CD5+ B1 cells to a macrophage-like morphology induced by gamma interferon and inhibited by interleukin-4. Clin. Diag. Lab. Immunol. 9:1169.
   PubMedGoogle Scholar
• J. A. Bennett, J. C. Marsh, and M. S. Mitchell. Suppressor macrophages: Their induction, characterization, and regulation. in: mediators of cellular immunity in cancer by immune modifiersM. A. Chirigos, and et al, and Raven Press, New York, (1981) .
   Google Scholar
• T. Kizaki, T. Ookawara, T. Izawa, N. Nagasawa, S. Haga, Z. Radiak, and H. Ohno. (1997). Relationship between cold tolerance and generation of suppressor macrophages during acute cold stress. J. Appl. Physiol. 83:1116–1122.
   PubMedGoogle Scholar
• S. Nabeshima, M. Numoyo, G. Matsuzaki, K. Kishihara, H. Taniguchi, S.-I. Yoshida, and K. Nomoto. (1999). T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect. Immun. 67:3221.
   PubMedGoogle Scholar
• R. T. Rahim, J. J. MeisslerJr., M. W. Adler, and T. K. Eisenstein. (2005). Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine. J. Leuk. Biol. 78:1185.
   PubMedGoogle Scholar
• P. Urso, Y. G. Wirsiy, W. Zhang, and P. J. Ans Moolenaar-Wirsiy. (2008). Alterations in CD4+, CD8+, Vagamma3, Vgammadelta, and for Valphabeta T-cell expression in lymphoid tissue of progeny after utero exposure to benzo (a) pyrene. J. Immunotox. In Press
   PubMedGoogle Scholar
• H. Folch, M. Yoshinaga, and B. H. Wasksman. (1973). Regulation of lymphocyte responses in vitro. III. Inhibition by adherent cells of the T-lymphocyte response to phytohemagglutinin. J. Immunol. 110:835.
   PubMedGoogle Scholar
• J. van Grevenynghe, L. Spaerfel, M. Le Vee, D. Gilot, B. Drenou, R. Fauchet, and O. Fardel. (2004). Cytochrome P450-dependent toxicity of environmental polycyclic aromatic hydrocarbons towards human macrophages. Biochem. Biophys. Res. Commu. 317:708.
   PubMed Web of Science ®Google Scholar